Center for Scientific Review; Notice of Closed Meetings, 63082 [2022-22585]
Download as PDF
<![CDATA[
63082
Federal Register / Vol. 87, No. 200 / Tuesday, October 18, 2022 / Notices
of information in 21 CFR part 601 have
been approved under OMB control
number 0910–0338.
III. Electronic Access
Persons with access to the internet
may obtain the draft guidance at https://
www.fda.gov/drugs/guidancecompliance-regulatory-information/
guidances-drugs, https://www.fda.gov/
regulatory-information/search-fdaguidance-documents, or https://
www.regulations.gov.
Dated: October 11, 2022.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2022–22617 Filed 10–17–22; 8:45 am]
BILLING CODE 4164–01–P
Meeting of the Tick-Borne Disease
Working Group
The Office of the Assistant
Secretary for Health published a notice
of an upcoming meeting of the TickBorne Disease Working Group (TBDWG)
in the Federal Register on September
16, 2022. This addendum provides
notice of an additional day added to the
October 25, 2022 meeting. The 24th
meeting of the TDBWG will now take
place from October 24–25, 2022. The
September 16th Federal Register notice
can be accessed at https://
www.federalregister.gov/documents/
2022/09/16/2022-20088/meeting-of-thetick-borne-disease-working-group.
DATES: The public can view the meeting
online via webcast on October 24 and
25, 2022 from approximately 9:00 a.m.
to 5:00 p.m. ET (times are tentative and
subject to change) each day. The
confirmed times and agenda items for
the meeting will be posted on the
TBDWG web page at https://
www.hhs.gov/ash/advisory-committees/
tickbornedisease/meetings/2022-10-25/
index.html when this information
becomes available.
SUPPLEMENTARY INFORMATION: As stated
in the Federal Register notice dated
September 16th, the public will have an
opportunity to present their views to the
TBDWG orally during the meeting’s
khammond on DSKJM1Z7X2PROD with NOTICES
19:52 Oct 17, 2022
Jkt 259001
James Berger, Designated Federal Officer
for the TBDWG; Office of Infectious
Disease and HIV/AIDS Policy, Office of
the Assistant Secretary for Health,
Department of Health and Human
Services, Tower Building, 1101 Wootton
Parkway, Rockville, MD 20852. Email:
tickbornedisease@hhs.gov. Phone: 202–
795–7608.
[FR Doc. 2022–22589 Filed 10–17–22; 8:45 am]
Office of Infectious Disease and
HIV/AIDS Policy (OIDP), Office of the
Assistant Secretary for Health (OASH),
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice; addendum to 87 FR
56964 published on September 16,
2022.
AGENCY:
VerDate Sep<11>2014
FOR FURTHER INFORMATION CONTACT:
Dated: September 30, 2022.
James Berger,
Designated Federal Officer, HHS Tick-Borne
Disease Working Group, Office of HIV/AIDS
and Infectious Disease Policy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
SUMMARY:
public comment session or by
submitting a written public comment.
Persons who wish to provide verbal or
written public comment should review
instructions at https://www.hhs.gov/
ash/advisory-committees/
tickbornedisease/meetings/2022-10-25/
index.html and respond by midnight
October 17, 2022 ET.
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Cardiovascular and Respiratory Diseases
Study Section.
Date: November 8–9, 2022.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammed F A
Elfaramawi, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
Room 1007F, Bethesda, MD 20892, (301)
480–1142, elfaramawimf@csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Cancer and Hematologic Disorders Study
Section.
Date: November 9–10, 2022.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW,
Washington, DC 20015.
Contact Person: Denise Wiesch, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3138,
MSC 7770, Bethesda, MD 20892, (301) 437–
3478, wieschd@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Renal and Urological Sciences.
Date: November 10, 2022.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ganesan Ramesh, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182
MSC 7818, Bethesda, MD 20892, (301) 827–
5467, ganesan.ramesh@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
22–002: Center for Rapid Surveillance of
Tobacco (CRST) to Assess Changes in Use
Behaviors, Product Marketing, and the
Marketplace (U01 Clinical Trial Not
Allowed).
Date: November 10, 2022.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D.
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 480–4097, maureen.shuh@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 12, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–22585 Filed 10–17–22; 8:45 am]
BILLING CODE 4140–01–P
E:\FR\FM\18OCN1.SGM
18OCN1
]]>Agencies
[Federal Register Volume 87, Number 200 (Tuesday, October 18, 2022)]
[Notices]
[Page 63082]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22585]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Cardiovascular and Respiratory Diseases
Study Section.
Date: November 8-9, 2022.
Time: 9 a.m. to 8 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mohammed F A Elfaramawi, Ph.D., Scientific
Review Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1007F, Bethesda, MD 20892, (301)
480-1142, [email protected].
Name of Committee: Population Sciences and Epidemiology
Integrated Review Group; Cancer and Hematologic Disorders Study
Section.
Date: November 9-10, 2022.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW, Washington, DC 20015.
Contact Person: Denise Wiesch, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3138, MSC 7770, Bethesda, MD 20892, (301) 437-
3478, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Renal and Urological Sciences.
Date: November 10, 2022.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ganesan Ramesh, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2182 MSC 7818, Bethesda, MD
20892, (301) 827-5467, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; RFA-OD-22-002: Center for Rapid Surveillance of Tobacco
(CRST) to Assess Changes in Use Behaviors, Product Marketing, and
the Marketplace (U01 Clinical Trial Not Allowed).
Date: November 10, 2022.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge II, 6701
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Maureen Shuh, Ph.D. Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892, (301) 480-4097,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 12, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-22585 Filed 10-17-22; 8:45 am]
BILLING CODE 4140-01-P
